Late-onset pulmonary arterial hypertension in association with graft-versus-host disease after allogeneic stem-cell transplantation

24Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Pulmonary arterial hypertension (PAH) has been reported only rarely after allografting. Cases have all been in young patients, occurred within 6 months of transplant and been attributed to direct toxicity of chemoradiotherapy on the pulmonary vasculature. This case describes the late onset of PAH in a 36-year-old woman on a background of acute and chronic graft-versus-host disease (GVHD). Open lung biopsy demonstrated medial hypertrophy and intimal proliferation in small pulmonary arteries and arterioles, with no evidence of secondary causes such as thromboembolism, vasculitis, interstitial lung disease, or obliterative bronchiolitis. Therapy with bosentan produced symptomatic improvement. While the possibility of coincidental "idiopathic" PAH cannot be excluded, the clinical context suggests that pulmonary vessels may be a target for GVHD post-allograft. © 2005 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Grigg, A., Buchanan, M., & Whitford, H. (2005). Late-onset pulmonary arterial hypertension in association with graft-versus-host disease after allogeneic stem-cell transplantation. American Journal of Hematology, 80(1), 38–42. https://doi.org/10.1002/ajh.20373

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free